© 2022 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.
Releases
| Title | Date | Size | View |
|---|---|---|---|
| Trading Halt | April 29, 2022 | 229 KB | Download |
| Appendix 4C Quarterly Cash Flow Report | April 29, 2022 | 462 KB | Download |
| Revised date for release of Quarterly Results | April 27, 2022 | 220 KB | Download |
| Quarterly Results and Investor Conference Call Notification | April 21, 2022 | 221 KB | Download |
| Appendix 4E (Rule 4.3A): Preliminary Final Report for the Year Ended 31 December 2021 | February 28, 2022 | 210 KB | Download |
| Osprey Medical Financial Results for FY2021 | February 28, 2022 | 505 KB | Download |
| Annual Meeting of Stockholders | February 1, 2022 | 207 KB | Download |
| Osprey demonstrates resilience through OUS sales | January 31, 2022 | 506 KB | Download |
| Quarterly Results and Investor Conference Call Notification | January 24, 2022 | 222 KB | Download |
| Osprey Medical to Present at Upcoming Investor Conferences | November 25, 2021 | 1 MB | Download |
| DyeVert™ is highlighted by leading experts for reduction of Acute Kidney Injury | October 28, 2021 | 265 KB | Download |
| Strategic distribution agreements lead to record sales in Europe | October 20, 2021 | 472 KB | Download |
| Quarterly Results and Investor Conference Call Notification | October 13, 2021 | 222 KB | Download |
| Osprey Medical’s DyeVert™ Technology Featured at Prominent Italian Society of Interventional Cardiology Scientific Meeting | October 11, 2021 | 218 KB | Download |
| Reverse Stock Split and Dispatch of Holding Statements | September 23, 2021 | 171 KB | Download |
| GE Healthcare ramps up promotion of Osprey Medical’s DyeVert System across Europe | September 23, 2021 | 16 MB | Download |
| ASX ANNOUNCEMENT – Results of Special Meeting of Stockholders | September 3, 2021 | 229 KB | Download |
| Consolidation/Split – OSP | August 20, 2021 | 25 KB | Download |
| Notice of Special Meeting of Stockholders | August 20, 2021 | 573 KB | Download |
| Global expansion strategy progress strengthens revenues in the first half of 2021 | August 17, 2021 | 299 KB | Download |
| Half-Year Information for Six Months Ended 30 June 2021 | August 17, 2021 | 467 KB | Download |
| Martin Emerson appointed to Osprey Medical’s Board of Directors | August 12, 2021 | 178 KB | Download |
| Osprey continues to deliver positive results through strategic distribution agreements | July 29, 2021 | 537 KB | Download |
| Quarterly Results and Investor Conference Call Notification | July 22, 2021 | 225 KB | Download |
| Osprey expands into Canada with MDL approval and exclusive GE Healthcare distribution agreement | July 20, 2021 | 262 KB | Download |
| Steven Brandt appointed to Osprey Medical’s Board of Directors | July 1, 2021 | 177 KB | Download |
| Results of 2021 Annual Meeting of Stockholders | May 11, 2021 | 261 KB | Download |
| Strong quarter for Osprey with continued growth in units and revenue | April 22, 2021 | 619 KB | Download |
| Notice of Annual Meeting of Stockholders | April 20, 2021 | 618 KB | Download |
| Quarterly Results and Investor Conference Call Notification | April 16, 2021 | 217 KB | Download |
| CEO Business Update Investor Presentation | April 16, 2021 | 18 MB | Download |
| Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations | March 30, 2021 | 252 KB | Download |
| Osprey expands US sales coverage | March 18, 2021 | 360 KB | Download |
| Osprey presents at ASX Small & Mid-Cap Conference and Oppenheimer Healthcare Conference | March 10, 2021 | 18 MB | Download |
| Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) | March 3, 2021 | 181 KB | Download |
| Osprey expands US sales coverage with new sales agency agreements | March 2, 2021 | 432 KB | Download |
| Osprey Medical Financial Results for FY2020 | February 26, 2021 | 250 KB | Download |
| Funding Update – Exercise of Options and PPP Loan | February 23, 2021 | 181 KB | Download |
| Notice of Final Exercise of Options and Underwriting Arrangements | February 12, 2021 | 474 KB | Download |
| 4C and Business Update | January 28, 2021 | 537 KB | Download |
| Quarterly Results and Investor Conference Call Notification | January 22, 2021 | 215 KB | Download |
| Osprey Investor Presentation | January 12, 2021 | 13 MB | Download |
| Osprey Investor Presentation | December 3, 2020 | 2 MB | Download |
| Osprey signs strategic sales agency agreement for new US region | November 26, 2020 | 288 KB | Download |
| Strong quarter for Osprey with milestone distribution agreements signed | October 29, 2020 | 529 KB | Download |
| Exercise of Options | October 21, 2020 | 176 KB | Download |
| Quarterly Results and Investor Conference Call Notification | October 21, 2020 | 213 KB | Download |
| Osprey receives Supplier Horizon Award from Premier Inc | September 29, 2020 | 239 KB | Download |
| Regional Health Care Group to distribute Osprey Medical kidney protection technology across Australia and New Zealand | September 24, 2020 | 261 KB | Download |
| Osprey to Present at the H.C. Wainwright 22nd Annual Global Investment Conference | September 15, 2020 | 211 KB | Download |
| Notice of Exercise of Options | September 14, 2020 | 177 KB | Download |
| Positive outlook following adjustments to COVID-19 | August 25, 2020 | 314 KB | Download |
| Appendix 4D Half-Year Report for the Six Months Ended 30 June 2020 | August 25, 2020 | 472 KB | Download |
| Resignation of Andy Jane from the Board of Directors | August 18, 2020 | 177 KB | Download |
| CE Marking received for core European product, DyeVert Power XT | August 13, 2020 | 312 KB | Download |
| GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI) | July 30, 2020 | 257 KB | Download |
| Positive traction in the Quarter that was defined by COVID-19 | July 28, 2020 | 536 KB | Download |
| Shortfall Placement Update and Quarterly Results Release Notification | July 15, 2020 | 227 KB | Download |
| Response to ASX Price Query | July 3, 2020 | 303 KB | Download |
| Results of 2020 Annual Meeting of Stockholders | June 19, 2020 | 227 KB | Download |
| 2020 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEO | June 19, 2020 | 11 MB | Download |
| Issue of Securities under Shortfall Placement | June 12, 2020 | 176 KB | Download |
| Appendix 2A: Application for quotation of +securities | June 12, 2020 | 279 KB | Download |
| Appendix 3G: Notification of issue, conversion or payment up of equity +securities | June 12, 2020 | 381 KB | Download |
| Notice of Exercise of Options | June 10, 2020 | 368 KB | Download |
| Osprey Medical successfully raises an additional $2.6m under Shortfall Placement | June 9, 2020 | 179 KB | Download |
| Trading Halt | June 4, 2020 | 365 KB | Download |
| Notice of Annual Meeting of Stockholders | May 29, 2020 | 3 MB | Download |
| ASX Announcement | May 29, 2020 | 164 KB | Download |
| DyeVert™ featured at the SCAI 2020 Scientific Session: Procedure-Based Strategies to reduce Contrast-Induced Acute Kidney Injury | May 28, 2020 | 223 KB | Download |
| Allotment of Securities under Entitlement Offer | May 1, 2020 | 118 KB | Download |
| Appendix 2A: Application for quotation of +securities | May 1, 2020 | 156 KB | Download |
| Appendix 3G: Notification of issue, conversion or payment up of equity +securities | May 1, 2020 | 140 KB | Download |
| Quarterly Results and COVID-19 Update | April 30, 2020 | 253 KB | Download |
| Completion of Entitlement Offer | April 29, 2020 | 182 KB | Download |
| Osprey Medical Secures US Government COVID-19 Relief Loan | April 29, 2020 | 175 KB | Download |
| Quarterly Results and Investor Conference Call Notification | April 17, 2020 | 215 KB | Download |
| ASX ANNOUNCEMENT: 2020 Annual Meeting of Stockholders | April 16, 2020 | 235 KB | Download |
| Dispatch of Prospectus, Entitlement and Acceptance Forms | April 15, 2020 | 785 KB | Download |
| Rights Commence Trading | April 7, 2020 | 184 KB | Download |
| ASX ANNOUNCEMENT: Entitlement Offer – Notification to Ineligible CDI Holders and Optionholders | April 6, 2020 | 196 KB | Download |
| Amended and Restated Certificate of Incorporation | April 3, 2020 | 634 KB | Download |
| Osprey Medical Prospectus | April 3, 2020 | 489 KB | Download |
| Proposed Issues of Securities | April 3, 2020 | 42 KB | Download |
| Osprey Medical Announces Capital Raising and Trading Update | April 3, 2020 | 129 KB | Download |
| Trading Halt | April 1, 2020 | 354 KB | Download |
| Appendix 4G Corporate Governance Council | March 26, 2020 | 204 KB | Download |
| ASX ANNOUNCEMENT – 2020 Annual Meeting of Stockholders | March 26, 2020 | 196 KB | Download |
| 4E Cover Memo | February 25, 2020 | 103 KB | Download |
| Osprey Medical Financial Results for FY2019 | February 25, 2020 | 222 KB | Download |
| Appendix 4E (Rule 4.3A): Preliminary Final Report for the Year Ended 31 December 2019 | February 24, 2020 | 550 KB | Download |
| UK NICE Issues Positive MedTech Innovation Briefing on DyeVert™ | February 10, 2020 | 229 KB | Download |
| ASX ANNOUNCEMENT – 2020 Annual Meeting of Stockholders | February 6, 2020 | 197 KB | Download |
| Appendix 4C: Quarterly report for entities subject to listing rule 7.8B | February 5, 2020 | 69 KB | Download |
| 36% Increase in DyeVert Unit Sales | January 31, 2020 | 499 KB | Download |
| Amendment to Quarterly Results and Investor Conference Call Notification | January 21, 2020 | 220 KB | Download |
| Quarterly Results and Investor Conference Call Notification | January 10, 2020 | 215 KB | Download |